XML 34 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Note 3 - Revenue (Tables)
6 Months Ended
Sep. 30, 2023
Notes Tables  
Disaggregation of Revenue [Table Text Block]
  

Three Months Ended September 30, 2023

 
  

Sterilization and Disinfection Control

  

Clinical Genomics

  

Biopharmaceutical Development

  

Calibration Solutions

  

Total

 
                     

Consumables

 $14,749  $9,963  $4,187  $786  $29,685 

Hardware and Software

  120   4,474   2,475   6,884   13,953 

Services

  2,211   1,112   2,545   3,659   9,527 

Total Revenues

 $17,080  $15,549  $9,207  $11,329  $53,165 
  

Three Months Ended September 30, 2022

 
  

Sterilization and Disinfection Control

  

Clinical Genomics

  

Biopharmaceutical Development

  

Calibration Solutions

  

Total

 
                     

Consumables

 $14,704  $12,399  $4,000  $865  $31,968 

Hardware and Software

  218   4,394   5,988   5,980   16,580 

Services

  2,042   1,642   2,156   4,361   10,201 

Total Revenues

 $16,964  $18,435  $12,144  $11,206  $58,749 
  

Six Months Ended September 30, 2023

 
  

Sterilization and Disinfection Control

  

Clinical Genomics

  

Biopharmaceutical Development

  

Calibration Solutions

  

Total

 

Consumables

 $28,456  $18,732  $8,673  $1,295  $57,156 

Hardware and Software

  201   7,901   5,166   13,962   27,230 

Services

  4,350   2,285   5,257   7,532   19,424 

Total Revenues

 $33,007  $28,918  $19,096  $22,789  $103,810 
  

Six Months Ended September 30, 2022

 
  

Sterilization and Disinfection Control

  

Clinical Genomics

  

Biopharmaceutical Development

  

Calibration Solutions

  

Total

 
                     

Consumables

 $26,932  $23,930  $7,664  $1,719  $60,245 

Hardware and Software

  524   5,885   10,812   11,673   28,894 

Services

  4,282   3,125   4,635   8,021   20,063 

Total Revenues

 $31,738  $32,940  $23,111  $21,413  $109,202 
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
  

Three Months Ended September 30,

  

Six Months Ended September 30,

 
  

2023

  

2022

  

2023

  

2022

 

United States

 $27,073  $30,989  $53,610  $60,111 

China

  7,529   7,480   13,642   11,177 

Other

  18,563   20,280   36,558   37,914 

Total revenues

 $53,165  $58,749  $103,810  $109,202 
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

Contract liabilities as of March 31, 2023

 $16,098 

Prior year contract liabilities recognized in revenues during the six months ended September 30, 2023

  (6,399)

Contract liabilities added during the six months ended September 30, 2023, net of revenues recognized

  4,934 

Contract liabilities balance as of September 30, 2023

 $14,633